Back |
home / stock / eq / eq message board
Subject | By | Source | When |
---|---|---|---|
EQ on the move | eastunder | investorshub | 07/22/2020 6:42:11 PM |
nice pop off day low 12.4 | saj | investorshub | 07/22/2020 5:47:29 PM |
EQ Continuing its retreat following good news. Will | MiamiGent | investorshub | 07/21/2020 5:03:51 PM |
znewcar1: EQ 23% v19,3M c17.33 f17,6M H3.47 S2.86 | znewcar1 | investorshangout | 07/15/2020 10:45:15 PM |
* * $EQ Video Chart 07-15-2020 * * | ClayTrader | investorshub | 07/15/2020 10:34:37 PM |
Took half from an ER play to get | MiamiGent | investorshub | 07/15/2020 8:09:01 PM |
The shorts here are nothing but idiots.. Itolizumab | David1991 | investorshub | 07/15/2020 8:02:06 PM |
Itolizumab is better than anything out there according | David1991 | investorshub | 07/15/2020 7:58:57 PM |
EQ $30 TARGET PRICE WOOHOOOOOOOOOOOOOOO | weedtrader420 | investorshub | 07/15/2020 7:43:28 PM |
Yess | starkd748 | investorshub | 07/15/2020 6:03:44 PM |
Getting back on traction again, imo | trademax42 | investorshub | 07/15/2020 1:48:25 PM |
EQ What a bummer this petered out. Good | MiamiGent | investorshub | 07/14/2020 4:54:30 PM |
The question is how low is this pos | Roadtojourney | investorshub | 07/14/2020 4:35:17 PM |
Lol loosing 50% already | Roadtojourney | investorshub | 07/14/2020 2:52:45 PM |
EQ Not happening so far. I've got to | MiamiGent | investorshub | 07/14/2020 2:40:04 PM |
lol better than me filled mid 15.8's | saj | investorshub | 07/14/2020 1:59:26 PM |
Ya I exited at 15.64 and got right | MiamiGent | investorshub | 07/14/2020 1:58:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Q2 ending cash, cash equivalents and short-term investments totaled approximately $33.3 million, an increase of approximately $1.0 million compared to the amount at the end of Q1 Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutic...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will be participating in the Leerink Partners Therapeutic Forum: I&I and Metabolism, as well as the Jone...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it expects to join the Russell Microcap Index at the conclusion of the 2024 Russell annual reconstitution, effe...